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ABSTRACT
Background: Recent studies suggest that Tc1Tc2 imbalances are implicated in the pathogenesis of chronic
obstructive pulmonary disease (COPD). The purpose of this study was to clarify the relationship between pe-
ripheral blood T-cell profiles and pulmonary function or inflammatory parameters.
Methods: Thirty-one patients with stable COPD (median age 70 years, 30 males, 15 current smokers and 16
ex-smokers) and 30 healthy control subjects were enrolled in this study. The subjects underwent blood tests,
exhaled nitric oxide (eNO) measurement, pulmonary function tests, and sputum induction. Tc1Tc2 and Th1
Th2 were determined by analyzing intracellular cytokine staining for IFN-γ and IL-4 in peripheral blood CD8+
and CD4+ T cells using flow cytometry after stimulation with phorbol 12-myristate 13-acetate and ionomycin.
Results: There was a significantly increased proportion of IFN-γ-producing and IL-4-producing CD8+ T cells in
patients with COPD compared with control subjects (median [IQR] 73.6% [63.9%-80.7%] vs 62.0% [45.6%-
73.8%], p = 0.004; and 2.6% [1.1%-6.9%] vs 1.1% [0.6%-2.2%], p = 0.002, respectively). In addition, the pro-
portion of IFN-γ-producing CD4+ T cells was significantly higher in patients with COPD compared with control
subjects (25.7% [21.2%-38.0%] vs 22.8% [15.6%-29.2%], p = 0.027). The proportion of IFN-γ-producing CD8+
T cells was correlated negatively with single-breath carbon monoxide transfer coefficient (Kco) (ρ = -0.45, p =
0.033) and positively with eNO (ρ = 0.50, p = 0.012). The proportion of IL-4-producing CD8+ T cells was posi-
tively correlated with body mass index (ρ = 0.42, p = 0.023) and Kco (ρ = 0.47, p = 0.026).
Conclusions: It is suggested that Tc1 cells have a detrimental role and that Tc2 cells have a protective role in
disease progression.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is
characterized by chronic inflammation in the respira-
tory tract with neutrophils, macrophages, and T lym-
phocytes.1,2 It is known that there is a greater in-
crease in CD8+ than CD4+ T cells in the airway wall
and lung parenchyma.3,4 It is suggested that the ma-
jority of T cells in COPD airways are of Tc1 (IFN-γ
producing) rather than Tc2 (IL-4-producing) sub-
types by immunohistochemical study.5
The flow cytometric method for examining intracel-
lular cytokine production at the single-cell level is
sensitive and does not need purification of peripheral
blood mononuclear cells, which might modify the cell
activation.6-9 Very few investigators have studied the
balance of Tc1 and Tc2 cells in peripheral blood from
patients with COPD using the flow cytometric
method. No increase or decrease of IFN-γ-producing
or IL-4-producing CD8+ T cells has been reported,10
whereas an increased proportion of IFN-γ-producing
CD4+, not CD8+, T cells has been found.11 Recent
studies have investigated cytokine production in
bronchoalveolar lavage or induced sputum T cells,
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Table 1 Characteristics of the study population†
Healthy control subjects (n = 30)Patients with COPD (n = 31)
67 (59-72)70 (62-75)Age, years
27/330/1Sex (male/female)
22.5 (20.9-24.8)21.5 (17.6-25.2)BMI, kg/m2
14/1615/16
Smoking history
　curent/ex-smoker
47 (38-75)51 (40-79)　pack-years
Not applicable11/12/8
Severity (GOLD)
　mild/moderate/severe
104.6 (96.6-113.9)63.5 (49.3-95.7) ‡FEV1, % predicted
83.3 (80.2-86.3)51.2 (43.4-64.9) ‡FEV1/FVC, %
106.6 (96.9-112.8)114.3 (102.3-120.0)TLC, % predicted
97.5 (86.1-104.2)101.6 (94.1-111.6)FRC, % predicted
109.0 (84.5-123.0)162.8 (132.3-183.1) ‡RV, % predicted
93.8 (90.4-97.0)57.4 (39.6-68.6) ‡Kco, % predicted
44.1 (25.5-57.6)58.3 (34.7-74.5)Sputum neutrophils, %
31.4 (23.3-37.5)26.3 (21.3-43.6)Exhaled NO, ppb
392 (235-881)1130 (397-2580) ‡Serum high sensitivity CRP, ng/ml
BMI, body mass index; GOLD, Global Initiative for Chronic Obstructive Lung Disease; FEV1, forced expiratory volume in 1 second; 
FVC, forced vital capacity; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume; Kco, carbon monoxide trans-
fer coeficient; NO, nitric oxide; CRP, C-reactive protein.
†Data are expressed as the median (IQR) or No.
‡P < 0.05 compared with the control group.
raising the possibility that Tc2, rather than Tc1 cells
might be predominant and that pulmonary T lympho-
cyte profiles might be different from those of periph-
eral blood10,12,13; thus, a consensus has not been es-
tablished.
There is increasing evidence of systemic as well as
local inflammation in patients with COPD. Induced
sputum neutrophil counts and exhaled nitric oxide
(NO) are useful markers of airway inflammation,14-16
while recent studies suggest that high sensitivity C-
reactive protein (CRP) levels may be systemic mark-
ers of the inflammatory process in COPD.17,18 Very
few studies have assessed the relationship between T
cell profiles and clinical parameters, including pulmo-
nary function tests. To our knowledge, no relation-
ship with systemic or airway inflammation has been
reported.
The purpose of this study was to clarify the bal-
ances of peripheral blood Tc1Tc2 and Th1Th2 in
patients with COPD compared with those in healthy
subjects, and the relationship between T-cell profiles
and pulmonary function or inflammatory parameters,
including induced sputum neutrophils, exhaled nitric
oxide, and serum high sensitivity CRP.
METHODS
SUBJECTS
Thirty-one patients with stable COPD and 30 healthy
control subjects were enrolled in this study (Table 1).
These consecutive patients with COPD first visited
Shizuoka General Hospital from May 2005 to October
2007. They satisfied the definition of the Global Initia-
tive for Chronic Obstructive Lung Disease (GOLD)1
and the severity was classified accordingly. The post-
bronchodilator forced expiratory volume in 1 second
(FEV1) and the ratio of FEV1 to forced vital capacity
(FVC) were determined 30 minutes after inhalation of
200 μg of salbutamol. All patients had a reversibility
of less than 12% in FEV1 before and 30 minutes after
inhalation of salbutamol, used bronchodilator therapy
only, and none had received oral or inhaled corti-
costeroids. Patients with COPD had no exacerba-
tions, defined as increased dyspnea associated with a
change in the quality and quantity of sputum, for at
least one month before the first visit.
All subjects of both groups were current or ex-
smokers. They were excluded from the study if they
(1) had any history of asthma; (2) had atopy, defined
by positive specific IgE antibodies to at least one in-
halant allergen, including house dust mites, grass
pollens, molds, cockroaches, cats, or dogs (CAP sys-
tem, Pharmacia, Uppsala, Sweden); (3) had any acute
viral infections within at least one month before the
study; and (4) had inflammatory disease in which
high CRP levels have been reported. The protocols
were approved by the local ethics committee and in-
formed consent was obtained from all patients prior
to the study.
STUDY DESIGN
The subjects underwent blood tests, exhaled NO
measurement, pulmonary function tests, and sputum
Peripheral Blood T-cell Profiles in COPD
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induction. Exhaled NO levels were measured by us-
ing the online method with an NO analyzer (Sievers
NOA 280i, Sievers, Boulder, Colorado, USA) accord-
ing to the American Thoracic SocietyEuropean Res-
piratory Society recommendations.19 Spirometry,
lung volumes, and transfer coefficient (Kco) were de-
termined using computerized equipment (model
CHESTAC-33; CHEST MI, Inc, Tokyo, Japan) accord-
ing to the recommendations of the American Tho-
racic Society.20,21 FEV1 and FVC were expressed as a
percentage of predicted values according to the for-
mula of the Japanese Respiratory Society.22 Total
lung capacity (TLC), functional residual capacity
(FRC), and residual volume (RV) were expressed as
a percentage of predicted values according to the for-
mula of Nishida.23 Kco for carbon monoxide was
measured by the single-breath method according to
the guidelines of the Japanese Respiratory Society.22
Results were corrected by haemoglobin concentra-
tion and expressed as a percentage of predicted val-
ues according to the formula of Burrows.24 Sputum
induction was performed according to the method de-
scribed previously.25 Serum high sensitivity CRP lev-
els were measured by the latex-enhanced immu-
nonephelometric method (N Latex CRP II, Dade
Behring, Deerfield, Illinois, USA). The minimal de-
tectable concentration of this assay system was 0.10
ngml.26
PREPARATION OF PERIPHERAL BLOOD CELLS
Ten milliliters of heparinized blood was collected
from each patient or control subject and diluted 1 : 20
with a culture medium consisting of RPMI-1640.
STIMULATION OF CELLS AND INTRACELLU-
LAR CYTOKINE STAINING
One milliliter of peripheral blood cells diluted 1 : 20 in
culture medium was stimulated with phorbol 12-
myristate 13-acetate (PMA; 25 ngml, Sigma, St
Louis, Missouri, USA) and ionomycin (1 μgml,
Sigma) in the presence of brefeldin-A (10 μgml,
Sigma) for 4 hours at 37℃.
After stimulation with PMAionomycin, the cells
were incubated with either peridin chlorophyll pro-
tein (PerCP)-conjugated anti-CD8 or anti-CD4 anti-
body (Becton Dickinson, San Jose, California, USA)
for 15 minutes at room temperature (RT). In the
preparation of peripheral blood cells, erythrocytes
were lysed by adding FACS Lysing Solution (Beckton
Dickinson). After centrifugation, the cells were
washed with 0.1% BSAPBS and subsequently incu-
bated in FACS Permeabilizing Solution (Beckton
Dickinson) for 10 minutes at RT. After washing with
0.1% BSAPBS, the permeabilized cells were then in-
cubated with fluorescein isothiocyanate (FITC)-
conjugated anti-IFN-γ and phycoerythrin (PE)-
conjugated anti-IL-4 antibodies for 30 minutes at RT.
After staining, they were washed with 0.1% BSAPBS,
fixed in 1% paraformaldehyde, and analyzed. Negative
controls consisted of unstimulated cells. We con-
firmed that the viability of the cells freshly obtained
from peripheral blood was greater than 97% by using
trypan blue exclusion. After PMAionomycin activa-
tion, the viability of each cell population was greater
than 95%.
FLOW CYTOMETRIC ANALYSIS
The samples were analyzed on a FACScan flow cy-
tometer (Beckton Dickinson) equipped with a 15-mW
argon ion laser and appropriate filters for FITC (530
nm), PE (585 nm), and PerCP (>650 nm) by using
the Cell Quest Software (Beckton Dickinson). Lym-
phocytes were first gated on the basis of forward and
side light scatter. Subsequently, within this gated
area, a second gate was further selected. The follow-
ing analyses were done on cells in the second gate.
For 3-colour analysis, we measured the number of
positive cells for anti-IFN-γ (FITC), anti-IL-4 (PE), or
both antibodies simultaneously in gated cell popula-
tions that were stained with either anti-CD8 or anti-
CD4 antibody (PerCP). The number of positive cells
for each cytokine was expressed as a percentage of
CD8+ or CD4+ T cells. In all experiments, parallel in-
cubations were performed with FITC- or PE-
conjugated irrelevant antibodies matched for the iso-
types of the anticytokine antibodies. The cutoff level
for the definition of positive cells was thus set so that
less than 1% of irrelevant antibody-stained cells was
positive.
STATISTICAL ANALYSIS
All data are expressed as medians with interquartile
ranges. Comparisons between groups were made
with the Mann-Whitney U test or the Kruskal-Wallis
test. Correlations between variables were done by us-
ing the Spearman rank correlation coefficient. Stat
View Version 5.0 (SAS Institute, Cary, North Caro-
lina, USA) was used for the statistical calculations. A
P value of less than 0.05 was considered significant,
and all tests were 2 sided.
RESULTS
CHARACTERISTICS OF THE STUDY POPULA-
TION
As shown in Table 1, patients with COPD had lower
FEV1, FEV1FVC, and Kco, and higher RV and se-
rum high sensitivity CRP levels compared with con-
trol subjects. There was no difference in exhaled NO
or sputum neutrophil counts between COPD and
healthy subjects. Table 2 shows the comparison of
characteristics according to the severity of COPD.
There were significant differences in body mass in-
dex, FEV1, FEV1FVC, and RV; however, no signifi-
cant difference was found in inflammatory parame-
ters among mild, moderate, and severe patients.
Shirai T et al.
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Table 2 Comparison of characteristics according to the severity of COPD†
p valueSevere (n = 8)Moderate (n = 12)Mild (n = 11)
0.16363 (60-71)70 (65-74)72 (65-76)Age, years
0.4418/011/111/0Sex (male/female)
0.04119.6 (16.3-23.8)19.4 (17.7-21.6)25.2 (21.5-26.5)BMI, kg/m2
0.8595/36/66/5
Smoking history
　curent/ex-smoker
0.26483 (37-112)51 (40-59)48 (43-54)　pack-years
<0.00139.8 (38.5-43.4)60.6 (57.7-67.9)105.8 (95.2-118.9)FEV1, % predicted
<0.00137.0 (36.2-40.3)49.1 (47.0-53.7)66.0 (60.0-67.6)FEV1/FVC, %
0.741107.7 (101.9-118.5)114.7 (101.5-122.6)115.8 (106.1-124.4)TLC, % predicted
0.275111.6 (99.5-115.9)100.5 (94.1-114.1)94.5 (93.6-108.0)FRC, % predicted
0.022183.1 (171.1-191.5)152.8 (137.0-181.4)129.7 (113.7-138.0)RV, % predicted
0.09049.0 (40.9-55.9)51.2 (36.7-67.0)69.1 (57.4-78.3)Kco, % predicted
0.97958.9 (54.5-67.0)58.8 (32.7-71.2)58.3 (31.2-85.8)Sputum neutrophils, %
0.37530.0 (25.9-47.2)24.2 (20.7-34.3)23.4 (19.8-43.8)Exhaled NO, ppb
0.158541 (369-1131)1080 (380-2263)2530 (581-4780)Serum high sensitivity CRP, ng/ml
0.68480.8 (57.1-84.4)71.5 (62.0-79.1)73.6 (63.9-80.7)IFN-γ-producing CD8+ T cels, %
0.9982.8 (0.9-5.1)2.5 (1.2-4.1)2.6 (1.1-6.9)IL-4-producing CD8+ T cels, %
0.99932.4 (11.8-99.3)30.5 (16.4-71.6)29.3 (9.3-117.9)IFN-γ-producing/IL-4-producing CD8+ T cels
0.42925.0 (18.1-31.2)28.2 (25.7-35.1)25.7 (21.2-38.0)IFN-γ-producing CD4+ T cels, %
0.1204.0 (2.9-5.5)2.1 (1.4-3.4)2.4 (1.5-3.4)IL-4-producing CD4+ T cels, %
0.51310.1 (6.5-7.7)14.9 (7.9-20.8)13.4 (7.9-17.5)IFN-γ-producing/IL-4-producing CD4+ T cels
BMI, body mass index; GOLD, Global Initiative for Chronic Obstructive Lung Disease; FEV1, forced expiratory volume in 1 second; 
FVC, forced vital capacity; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume; Kco, carbon monoxide trans-
fer coeficient; NO, nitric oxide; CRP, C-reactive protein.
†Data are expressed as the median (IQR) or No.
PERIPHERAL BLOOD T-CELL PROFILES: COM-
PARISON BETWEEN PATIENTS WITH COPD
AND HEALTHY SUBJECTS
Under unstimulated conditions, we could find no
cytokine-expressing cells in the CD8+ or CD4+ T-cell
population of peripheral blood cells in patients or
healthy control subjects.
According to the response to PMAionomycin
stimulation, each CD8+ or CD4+ T-cell was divided
into 4 subsets: IFN-γ (+) IL-4 (-), type 1 cell; IFN-γ (-)
IL-4 (+), type 2 cell; IFN-γ (+) IL-4 (+), type 0 cell; and
IFN-γ (-) IL-4 (-), naive cell. We studied the propor-
tion of type 1 and type 2 cells and the ratio of type 1
type 2 cells.
The proportion of IFN-γ-producing and IL-4-
producing CD8+ T cells were significantly higher in
patients with COPD than in healthy control subjects
(median [IQR] 73.6% [63.9%-80.7%] vs 62.0% [45.6%-
73.8%], p = 0.004, Fig. 1, upper left panel; and 2.6%
[1.1%-6.9%] vs 1.1% [0.6%-2.2%], p = 0.002, Fig. 1, upper
middle panel). In addition, the proportion of IFN-γ-
producing CD4+ T cells was significantly higher in pa-
tients with COPD than in healthy control subjects
(25.7% [21.2%-38.0%] vs 22.8% [15.6%-29.2%], p = 0.027,
Fig. 1, lower left panel).
However, there was no difference in the proportion
of IL-4-producing CD4+ T cells or in the ratio of IFN-
γ-producingIL-4-producing CD8+ or CD4+ T cells be-
tween the 2 groups (Fig. 1, upper right, and lower
middle and right panels).
PERIPHERAL BLOOD T-CELL PROFILES: EF-
FECT OF SMOKING AND DISEASE SEVERITY
There was no significant difference in the proportion
of IFN-γ- or IL-4-producing CD8+ or CD4+ T cells or in
the ratio of IFN-γ-producingIL-4-producing CD8+ or
CD4+ T cells between smokers and ex-smokers. Nei-
ther was any difference among patients with mild,
moderate, and severe COPD (Table 2).
CORRELATION BETWEEN T-CELL PROFILES
AND CLINICAL AND INFLAMMATORY PARAME-
TERS IN PATIENTS WITH COPD
As shown in Table 3, the proportion of IFN-γ-
producing CD8+ T cells was correlated negatively
with Kco and positively with eNO (Fig. 2). The pro-
portion of IL-4-producing CD8+ T cells was positively
correlated with BMI and Kco. In addition, the ratio of
IFN-γ-producingIL-4-producing CD8+ T cells was
negatively correlated with BMI and Kco. There was
no correlation between CD8+ T cell profiles and other
parameters.
The proportion of IL-4-producing CD4+ T cells was
negatively correlated with FEV1FVC, and the ratio
Peripheral Blood T-cell Profiles in COPD
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Fig. 1 The percentage of IFN-γ (+)/IL-4 (-) CD8+ T cels and IFN-γ (-)/IL-4 (+) CD8+ T cels, the ratio of IFN-γ (+)/IL-4 (-) 
CD8+ T cels to IFN-γ (-)/IL-4 (+) CD8+ T cels, the percentage of IFN-γ (+)/IL-4 (-) CD4+ T cels and IFN-γ (-)/IL-4 (+) CD4+ T 
cels, and the ratio of IFN-γ (+)/IL-4 (-) CD4+ T cels to IFN-γ (-)/IL-4 (+) CD4+ T cels obtained from peripheral blood after 
stimulation with PMA/ionomycin. Horizontal lines, boxes, whiskers, and circles represent median values, the interquartile 
range, 10th or 90th percentiles, and data apart from 10th or 90th percentiles, respectively. *P < 0.05.
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Table 3 Corelations between CD8+ T cels and clinical and inflammatory parameters in patients with COPD†
IFN-γ-producing/IL-4-producing 
CD8+ T celsIL-4-producing CD8
+ T celsIFN-γ-producing CD8+ T cels
-0.430.42-0.33BMI
p = 0.020p = 0.023
0.06-0.060.33Pack-years
-0.080.08-0.10FEV1
-0.040.04-0.11FEV1/FVC
0.14-0.150.11TLC
0.13-0.150.10FRC
0.20-0.210.22RV
-0.480.47-0.45Kco
p = 0.025p = 0.026p = 0.033
-0.080.06-0.13Sputum neutrophils
0.32-0.300.50Exhaled NO
p = 0.012
-0.020.040.07High sensitivity CRP
BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; TLC, total lung capacity; FRC, func-
tional residual capacity; RV, residual volume; Kco, carbon monoxide transfer coeficient; NO, nitric oxide; CRP, C-reactive protein.
†Values are the corelation coeficient with statistical significance. If only a number is shown, it is not significant.
of IFN-γ-producingIL-4-producing CD4+ T cells was
positively correlated with FEV1 and FEV1FVC (Ta-
ble 4); however, the association was weak in view of
each correlation coefficient value.
No correlation was found between CD4+ T cell pro-
files and other parameters.
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Fig. 2 Corelations between the proportion of IFN-γ (+)/IL-4 (-) CD8+ T cels and transfer coeficient 
(Kco) and exhaled nitric oxide (eNO).
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Table 4 Corelations between CD4+ T cels and clinical and inflammatory parameters in patients with COPD†
IFN-γ-producing/IL-4-producing 
CD4+ T celsIL-4-producing CD4
+ T celsIFN-γ-producing CD4+ T cels
0.04-0.04-0.04BMI
-0.110.11-0.01Pack-years
0.36-0.300.08FEV1
p = 0.049
0.39-0.370.03FEV1/FVC
p = 0.033p = 0.045
-0.040.230.29TLC
-0.200.190.11FRC
-0.370.35-0.01RV
0.000.06-0.10Kco
-0.040.11-0.00Sputum neutrophils
0.13-0.100.07Exhaled NO
0.12-0.13-0.04High sensitivity CRP
BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; TLC, total lung capacity; FRC, func-
tional residual capacity; RV, residual volume; Kco, carbon monoxide transfer coeficient; NO, nitric oxide; CRP, C-reactive protein.
†Values are the corelation coeficient with statistical significance. If only a number is shown, it is not significant.
DISCUSSION
In this study we found a significantly higher percent-
age of IFN-γ-producing and IL-4-producing CD8+ T
cells in peripheral blood after PMAionomycin stimu-
lation in patients with COPD compared with healthy
control subjects. Considering the high proportion of
IFN-γ-producing CD8+ T cells, our results provide in-
direct support for Tc1 predominance in the lungs
shown by an immunohistochemical study.5 In addi-
tion, a higher proportion of IFN-γ-producing CD4+ T
cells was found in COPD patients than in control sub-
jects.
The profiles of cytokine production in peripheral
blood T cells in patients with COPD have been re-
ported previously.10,11 Barceló et al. showed no differ-
ence in the proportion of IFN-γ-producing or IL-4-
producing CD8+ T cells between patients with COPD
and control subjects.10 Majori et al. also showed no
difference in the percentage of Tc1 or Tc2 cells11;
however, a significantly increased proportion of IFN-
γ-producing and a reduced proportion of IL-4-
producing CD4+ T cells were found in COPD patients
compared with control subjects.11 Th1 predominance
in the latter report is consistent with our study; how-
ever, there are several differences in other results.
Basically, there is no difference in methodology be-
tween these reports and our study. No subjects had
received oral or inhaled corticosteroids in our study,
whereas some of the patients studied by Barceló et al.
were given inhaled corticosteroid. Overall, our pa-
tients had milder COPD as reflected by a median
%FEV1 of 63.5%, compared with 42.4% in the study re-
ported by Majori et al. These could all be causes of
the discrepancy.
Recently, Zhu et al. also reported an increase of Tc
1 and Tc2 in the peripheral blood in patients with
COPD compared with lifelong nonsmoking, control
Peripheral Blood T-cell Profiles in COPD
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subjects.27 Koch et al. found an increased expression
of the Tc1-specific chemokine receptor CXCR3+ by
blood CD8+ T cells in smokers with COPD compared
with smokers without COPD and controls, and an in-
creased expression of activated and cytotoxic effector
CD8+ T cells in smokers with and without COPD
compared with controls.28 These findings suggest the
possibility that the increase of Tc1 (and possibly Tc2)
may be induced by smoking.
Recent studies have investigated cytokine produc-
tion by bronchoalveolar lavage T lymphocytes and
found an increased population of CD8+ cells differen-
tiated into the Tc2 rather than the Tc1 profile in the
lungs of patients with COPD.10,12 In contrast, in a
study reported by Tzanakis et al., there was a signifi-
cantly lower proportion of Tc1 and Tc2 subtypes and
a higher ratio of Tc1Tc2 in induced sputum T cells
in the patients compared with the control subjects,
raising the possibility that airway T lymphocyte pro-
files might be different from those of peripheral
blood.13 Thus, a consensus has not been established
and further studies should clarify whether Tc1 or Tc2
cells are predominant in the peripheral blood or
lungs of COPD patients.
We found a negative correlation between the pro-
portion of IFN-γ-producing CD8+ T cells and the ratio
of IFN-γ-producingIL-4-producing CD8+ T cells and
Kco. Also, we found a positive correlation between
the proportion of IL-4-producing CD8+ T cells and
Kco. These results suggest that Tc1 cytokine produc-
tion might be parallel and Tc2 cytokine production
might be the reverse of the degree of gas exchange
abnormalities. We also found a positive correlation
between the proportion of IL-4-producing CD8+ T
cells and BMI, which was significantly higher in pa-
tients with mild COPD compared with severer pa-
tients. Overall, it is possible that Tc2 cells play a pro-
tective role against Tc1 cells in the inflammatory
process of the disease. Other investigators have also
reported a relationship between T-cell profiles and
pulmonary function. Barceló et al. found a negative
correlation between the proportion of IL-4-producing
CD8+ bronchoalveolar lavage T cells and FEV1,10
whereas Tzanakis N et al. reported a positive correla-
tion between the ratio of IFN-γ-producingIL-4-
producing CD8+-induced sputum T cells and FEV1.13
Kim et al. found that COPD patients with normal dif-
fusing capacity (DLCOVA = 80%) had a significantly
higher proportion of CD8+ T lymphocytes than
healthy smokers but they did not study the cell types,
Tc1 or Tc2.29 The selective recruitment of cells out of
the blood into the tissue, and out of the tissue into the
lumen may cause differences between these compart-
ments.
We also found a positive correlation between the
proportion of IFN-γ-producing CD8+ T cells and eNO.
Previous studies demonstrated a negative correlation
between exhaled NO levels or induced sputum neu-
trophil counts and FEV1,14-16 while recent studies
have shown that eNO is not associated with the se-
verity of COPD30 and that various factors, including
eNO, airflow limitation, and sputum eosinophils and
neutrophils are separate and largely independent
components of COPD pathophysiology.31 In general,
exaggerated active oxygen intermediates are thought
to convert NO to nitric metabolites, thereby reducing
the airway NO levels in COPD.32 In addition, NO is
induced from epithelial cells by IFN-γ.33,34 Taken to-
gether, our findings do not imply a direct relationship
between Tc1 cells and airway inflammation.
The proportion of IFN-γ-producing CD4+ T cells
was higher in COPD patients than control subjects,
but there was no correlation between clinical or in-
flammatory parameters. Also, there was a positive
correlation between the proportion of IL-4-producing
CD4+ T cells and FEV1FVC, but the association was
weak. These findings suggest that CD4+ T cells might
also play a role in the pathogenesis of COPD, but the
mechanisms are unclear.
We did not study the proportions of CD4+ or CD8+
T cells in peripheral blood. There are conflicting re-
sults about this in the literature. No increase or de-
crease of CD4+ (range: 35% to 70%) or CD8+ T cells
(range: 20% to 30%) compared with controls has been
reported,10,11,27 whereas an increased proportion of
CD4+ T cells27 or decreased CD8+ T cells28 has been
found.11
In conclusion, both Tc1 and Tc2 cell proportions
are higher in the peripheral blood of stable COPD pa-
tients than in healthy controls. The proportion of Tc1
cells is parallel to the degree of gas exchange abnor-
malities, while the proportion of Tc2 has an opposite
degree of gas exchange abnormalities. It is suggested
that Tc1 cells have a detrimental role and that Tc2
cells have a protective role in the progression of
COPD.
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